|
1
|
Ryeom S and Folkman J: Role of endogenous
angiogenesis inhibitors in Down syndrome. J Craniofac Surg.
20(Suppl 1): S595–S596. 2009. View Article : Google Scholar
|
|
2
|
Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason
GA, Christensen JG and Kerbel RS: Accelerated metastasis after
short-term treatment with a potent inhibitor of tumor angiogenesis.
Cancer Cell. 15:232–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Demetri GD, van Oosterom AT, Garrett CR,
Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich
MC, Morgan JA, et al: Efficacy and safety of sunitinib in patients
with advanced gastrointestinal stromal tumour after failure of
imatinib: A randomised controlled trial. Lancet. 368:1329–1338.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Motzer RJ, Michaelson MD, Redman BG, Hudes
GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE,
et al: Activity of SU11248, a multitargeted inhibitor of vascular
endothelial growth factor receptor and platelet-derived growth
factor receptor, in patients with metastatic renal cell carcinoma.
J Clin oncol. 24:16–24. 2006. View Article : Google Scholar
|
|
5
|
Xu H, Pan L, Ren Y, Yang Y, Huang X and
Liu Z: RGD-modified angiogenesis inhibitor HM-3 dose: Dual function
during cancer treatment. Bioconjug Chem. 22:1386–1393. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan D, Shen H, Yuan S, Liu X, Xia X, Xie
P, Li W, Hu J, Liu Q and Xu H: Pharmacokinetics of HM-3 after
intravitreal administration in mice. Curr Eye Res. 39:837–844.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou K, Zheng X, Xu HM, Zhang J, Chen Y,
Xi T and Feng T: Studies of poly(ethylene glycol) modification of
HM-3 polypeptides. Bioconjug Chem. 20:932–936. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu B, Xu HM, Zhao L, Huang X and Zhang F:
Site-specific modification of anti-angiogenesis peptide HM-3 by
polyethylene glycol molecular weight of 20 kDa. J Biochem.
148:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Z, Ren Y, Pan L and Xu HM: In vivo
anti-tumor activity of polypeptide HM-3 modified by different
polyethylene glycols (PEG). Int J Mol Sci. 12:2650–2663. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View
Article : Google Scholar
|
|
11
|
Silginer M, Burghardt I, Gramatzki D,
Bunse L, Leske H, Rushing EJ, Hao N, Platten M, Weller M and Roth
P: The aryl hydrocarbon receptor links integrin signaling to the
TGF-β pathway. Oncogene. 10:3872015.
|
|
12
|
Yan F, Xu X, Chen Y, Deng Z, Liu H, Xu J,
Zhou J, Tan G, Wu J and Zheng H: A lipopeptide-based
αvβ3 integrin-targeted ultrasound contrast agent for
molecular imaging of tumor angiogenesis. Ultrasound Med Biol.
41:2765–2773. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang C, Jacobson K and Schaller MD: MAP
kinases and cell migration. J Cell Sci. 117:4619–4628. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong F, Tian H, Yan S, Li L, Dong X, Wang
F, Li J, Li C, Cao Z, Liu X, et al: Dihydroartemisinin inhibits
endothelial cell proliferation through the suppression of the ERK
signaling pathway. Int J Mol Med. 35:1381–1387. 2015.PubMed/NCBI
|
|
15
|
Huang Y, Yu J, Wan F, Zhang W, Yang H,
Wang L, Qi H and Wu C: Panaxatriol saponins attenuated
oxygen-glucose deprivation injury in PC12 cells via activation of
PI3K/Akt and Nrf2 signaling pathway. Oxid Med Cell Longev.
2014:9780342014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsumoto K and Ema M: Roles of VEGF-A
signalling in development, regeneration, and tumours. J Biochem.
156:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ferrara N: Pathways mediating
VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev.
21:21–26. 2010. View Article : Google Scholar
|
|
18
|
Cathcart J, Pulkoski-Gross A and Cao J:
Targeting matrix metalloproteinases in cancer: Bringing new life to
old ideas. Genes Dis. 2:26–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
